Skip to main content
Log in

Economics of different treatment options of benign prostatic hyperplasia in Turkey

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Benign prostatic hyperplasia (BPH) has an important impact on the national health economics and can be managed in a large spectrum of modalities from simple follow-up to surgery. In this study, we aimed to compare different treatment options of BPH in terms of cost effectiveness in Turkey. The first evaluation of a BPH patient has a cost of $200. The cost of TURP or open prostatectomy (OP) in our hospital including all the expenses is $740. Finasteride has an annual cost nearly equal to TURP and OP. Considering the expenses of the close follow-up studies and regular visits, one-year lasting Finasteride treatment is two times more expensive than surgery. In comparison with medical treatment options, TURP as the gold standard of treatment of BPH is cost effective when long-term expenses are considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Drummond, M. F., McGuire, A. J., Black, N. A., Petticrew, M., McPherson, C. K.: Economic burden of treated benign prostatic hyperplasia in the United Kingdom.Br. J. Urol., 71, 290 (1993).

    Article  PubMed  CAS  Google Scholar 

  2. Goluboff, E. T., Olsson, C. A.: Urologist on a tightrope: Coping with a changing economy.J. Urol., 151, 1 (1994).

    PubMed  CAS  Google Scholar 

  3. Di Silverio, F., D'Eramo, G., Flammia, G. P., Sciarra, A., Buscarini, M., Mauro, M., Sciarra, F.: Cost effectiveness in the management of benign prostatic hyperplasia: Italian data.Minerva Urol. Nephrol., 46 (2), 93 (1994).

    Google Scholar 

  4. Ersev, D., Ilker, Y., Şimşek, F., Kuyumcuoĝlu, U., Akdaş, A.: Preliminary results of transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia in Turkey.Eur. Urol., 21, 187 (1992).

    PubMed  CAS  Google Scholar 

  5. Doll, H. A., Black, N. A., Food, A. B.: Patient perceived health status before and up to 12 months after transurethral resection of the prostate for benign prostatic hypertrophy.Br. J. Urol., 71 (3), 297 (1993).

    PubMed  CAS  Google Scholar 

  6. Holtgrewe, H. L., Ackerman, R., Bay-Nielsen, H., Coast, J., Jonsson, B., Levy, E., Mazeman, E., Standaert, B., Tajima, A., Thibault, P.: The economics of BPH. In: Cockett, A. T. K., Khoury, S., Chatelain, C., Denis, L., Griffiths, K., Murphy, G. (eds): Proceedings of the 2nd International Consultation on Benign Prostatic Hyperplasia, Paris, June 27–30, 1993, pp. 37–44.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ilker, Y., Tarcan, T. & Akdaş, A. Economics of different treatment options of benign prostatic hyperplasia in Turkey. International Urology and Nephrology 28, 525–528 (1996). https://doi.org/10.1007/BF02550960

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550960

Keywords

Navigation